MabThera 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung

7680543780176 CH-54378 Konzentrat
MabThera 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
MabThera 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
MabThera 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
2
Selling units
2
Measure
Durchstechflasche(n)
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
10/01/2024
Summary of Product Characteristics
Français
10/01/2024
Summary of Product Characteristics
Italien
10/01/2024

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
52.6 MG Substance HBESI

Reimbursement information

Public price
CHF 518.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1998

Authorization holder

Roche Pharma (Schweiz) AG

4058 Basel

Authorization information

Swissmedic authorization number
54378
Drug name
MabThera, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOPA
ATC Code
L01FA01
Authorization status
Z
Dispensing category
A
First authorization
27/11/1997
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Non-Hodgkin-Lymphom, Rheumatoide Arthritis, ANCA-assoziierte Vasculitis

Package details

Description (FR)
MABTHERA conc perf 100 mg/10 ml 2 flac 10 ml
Description (DE)
MABTHERA Inf Konz 100 mg/10 ml 2 Durchstf 10 ml
Market launch
27/11/1997
Narcotic (BTM)
No

Other package sizes (1)

MABTHERA conc perf 500 mg/50 ml flac 50 ml
1 DUR
GTIN: 7680543780251
View